Ad is loading...
BEAM
Price
$23.58
Change
-$0.91 (-3.72%)
Updated
Nov 21 closing price
102 days until earnings call
EDIT
Price
$2.41
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
96 days until earnings call
Ad is loading...

BEAM vs EDIT

Header iconBEAM vs EDIT Comparison
Open Charts BEAM vs EDITBanner chart's image
Beam Therapeutics
Price$23.58
Change-$0.91 (-3.72%)
Volume$1.01M
CapitalizationN/A
Editas Medicine
Price$2.41
Change-$0.00 (-0.00%)
Volume$2.82M
CapitalizationN/A
BEAM vs EDIT Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. EDIT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Sell and EDIT is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BEAM: $23.58 vs. EDIT: $2.37)
Brand notoriety: BEAM and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 94% vs. EDIT: 130%
Market capitalization -- BEAM: $2.03B vs. EDIT: $198.94M
BEAM [@Biotechnology] is valued at $2.03B. EDIT’s [@Biotechnology] market capitalization is $198.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • EDIT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -10.38% price change this week, while EDIT (@Biotechnology) price change was -14.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

EDIT is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.03B) has a higher market cap than EDIT($199M). BEAM YTD gains are higher at: -13.373 vs. EDIT (-76.604). BEAM has higher annual earnings (EBITDA): -160.83M vs. EDIT (-222.63M). BEAM has more cash in the bank: 926M vs. EDIT (265M). EDIT has less debt than BEAM: EDIT (38.5M) vs BEAM (162M). BEAM has higher revenues than EDIT: BEAM (350M) vs EDIT (61.8M).
BEAMEDITBEAM / EDIT
Capitalization2.03B199M1,019%
EBITDA-160.83M-222.63M72%
Gain YTD-13.373-76.60417%
P/E RatioN/AN/A-
Revenue350M61.8M566%
Total Cash926M265M349%
Total Debt162M38.5M421%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMEDIT
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLVRX23.250.33
+1.44%
JPMorgan Large Cap Value R5
JSVZX27.430.39
+1.44%
JPMorgan Small Cap Value R2
ADGGX31.760.12
+0.38%
American Century Disciplined Growth R5
NUIIX29.480.06
+0.20%
Nuveen International Dividend Growth I
GSZPX28.45N/A
N/A
Goldman Sachs Small Cap Gr Insghts P

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with NTLA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-1.66%
NTLA - EDIT
64%
Loosely correlated
+5.18%
CRSP - EDIT
64%
Loosely correlated
-2.05%
BEAM - EDIT
64%
Loosely correlated
-3.72%
VERV - EDIT
54%
Loosely correlated
+1.10%
AXON - EDIT
52%
Loosely correlated
+3.52%
More